Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

Blood Adv. 2021 Dec 14;5(23):5344-5348. doi: 10.1182/bloodadvances.2021005020.

Authors

Vanessa E Kennedy¹, Christopher Wong², Chiung-Yu Huang³, Swetha Kambhampati¹, Jeffrey Wolf¹, Thomas G Martin¹, Nina Shah¹, Sandy W Wong¹

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
² School of Medicine, Touro University California, Vallejo, CA; and.
³ Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.

No abstract available

MeSH terms

B-Cell Maturation Antigen
Humans
Macrophage Activation Syndrome*
Multiple Myeloma*
Receptors, Chimeric Antigen*
T-Lymphocytes

Substances

B-Cell Maturation Antigen
Receptors, Chimeric Antigen